Recruiting

THC & CBD

Sponsor:

L. Cinnamon Bidwell

Code:

NCT07679581

Conditions

Cannabis

Memory

Electroencephalography

Eligibility Criteria

Sex: All

Age: 21 - 40

Healthy Volunteers: Accepted

Interventions

Cannabis (smoked flower)

Study Details

Brief summary:

This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.

Conditions

Cannabis

Memory

Electroencephalography

Study ID

NCT07679581

Start date

Dec 10, 2025

Status verified date

Jun, 2026

Completion date

May 31, 2027

Anticipated

Primary completion date

Feb 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21 - 40

Healthy Volunteers: Accepted

1. Must be between the ages of 21 and 40 and provide informed consent;
2. Must be right-handed (Laterality Quotient > 60 on Edinburgh Handedness Inventory - Short Form136);
3. Heavy users (HU) in Experiments 1, 2, 3, and 4:

1. Must use cannabis at least 4 days during the month;
2. Must be a cannabis user for at least a year;
4. Non-users (NU) in Experiment 2:

1. Must not have used cannabis for prior 6 months;
2. Must have at least one episode of lifetime cannabis use;
5. Must self-report not using other illicit recreational drugs (e.g., cocaine, benzodiazepines (non-prescription), opiates (non-prescription), MDMA, sedatives, or methamphetamine) in the past 30 days, during the Pre-Screening;
6. Must not test positive on a urine toxicology test for drugs of abuse at the Baseline Appointment (TDS);
7. Must not be using psychotropic medications, however anti-depressant, non-benzodiazepine anti-anxiety, and ADHD medications are ok. ADHD medication users must be willing to abstain from ADHD medication use on appointment days; ADHD medications, even extended-release forms, are short acting and medication" holidays" (e.g., on weekends and holidays) are routine in individuals prescribed ADHD medications, without adverse effects.
8. Must not be a regular nicotine user (≤4 days per week; cigarette, E-cigs, or smokeless);
9. Must not have used caffeine or nicotine (cigarette, E-cigs, or smokeless) for 4 hours;
10. Must have a breath alcohol level of 0 at screening (to sign consent form);
11. Must not be actively seeking or in treatment for any substance use disorder (drug use levels will be carefully monitored via Timeline Follow Back (TLFB) throughout the study to assess any confounding influences of drug or alcohol use;
12. Female subjects must not be or trying to become pregnant (as indicated by a pregnancy test \& screening form administered at Baseline);
13. Must not be in treatment for psychotic disorder or bipolar disorder; or have a history with these disorders;
14. Must not have any physical characteristics (e.g., thick hair, head size exceeding the limit of the net, dyed hair) or experience any technical difficulties during testing that result in a poor-quality EEG recording.
15. Participants in Experiment 4 a. Must not have participated in Experiment 3

Study Design

Enrollment

64 participants

Anticipated

Interventions and Outcome Measures

Interventions

Cannabis (smoked flower)

Self directed use (ad libitum)

Primary outcome measure

  • Difference in ERP amplitude (FN400) [ Time Frame: Intoxicated session and not-intoxicated session (about 1 week) ]
  • Difference in ERP amplitude (parietal) [ Time Frame: Intoxicated session and not-intoxicated session (about 1 week) ]
  • Difference in retrieval memory accuracy [ Time Frame: Intoxicated session and not-intoxicated session (about 1 week) ]
  • Difference in retrieval memory performance [ Time Frame: Intoxicated session and not-intoxicated session (about 1 week) ]

Central Contacts and Locations

Central contacts

Locations

Center for Innovation and Creativity (CINC)

Recruiting

Boulder, Colorado, United States, 80301

Contacts

Principal Investigator:

Timothy Curran, Ph.D.

More Information

Sponsor

L. Cinnamon Bidwell

Last update posted

Jul 1, 2026

Last verified

Jun, 2026

Keywords

  • Cannabis
  • Memory
  • Electroencephalography

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by L. Cinnamon Bidwell on 2026-07-01.